BIOMIND LABS INC. (3XI) — Financial Flexibility Index
Latest as of September 2025:
-0.02x
BIOMIND LABS INC. (3XI) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of €-38.70K (operating CF €-38.70K minus capex €0.00) represents 0% of total liabilities (€1.62 Million).
Financial Flexibility Index
-0.02x
Free Cash Flow / Total Liabilities
Free Cash Flow
€-38.70K
Operating CF − Capex
Total Liabilities
€1.62 Million
EUR
Capital Expenditures
€0.00
EUR
BIOMIND LABS INC. Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for BIOMIND LABS INC. across 4 annual periods. See BIOMIND LABS INC. (3XI) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BIOMIND LABS INC. (2021–2024)
Year-by-year free cash flow to debt coverage for BIOMIND LABS INC.. For the full company profile including market capitalisation, see BIOMIND LABS INC. (3XI) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.26x | €-354.43K | €-354.43K | €1.34 Million | ▲ +48.0% |
| 2023 | -0.51x | €-765.93K | €-765.93K | €1.51 Million | ▲ +92.0% |
| 2022 | -6.39x | €-2.15 Million | €-2.15 Million | €336.72K | ▼ -3.0% |
| 2021 | -6.20x | €-2.08 Million | €-2.12 Million | €334.95K | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities